| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/25/2011 | CN101170899B Wheat containing novel starch and method of producing the same |
| 05/25/2011 | CN101120015B Interleukin-15 antagonist peptide |
| 05/25/2011 | CN101100666B Human TCRVbeta7.1_H3F7 gene and its screening method and application |
| 05/25/2011 | CN101074265B Recombinant anti-TNFR monoclonal antibody, its production and use |
| 05/25/2011 | CN101074262B Recombinant anti-FL moncclonal antibody, its production and use |
| 05/25/2011 | CN101063149B Agriculture bacillus mediated alfalfa genetic conversion method |
| 05/24/2011 | US7947884 Plants and seeds of hybrid corn variety CH244084 |
| 05/24/2011 | US7947883 Plants and seeds of hybrid corn variety CH626994 |
| 05/24/2011 | US7947882 Plants and seeds of hybrid corn variety CH226886 |
| 05/24/2011 | US7947881 Cotton variety 07W514DF |
| 05/24/2011 | US7947880 Cotton variety MX0623B2RF |
| 05/24/2011 | US7947879 Soybean cultivar 04KG128257 |
| 05/24/2011 | US7947878 Soybean cultivar S07-04KL905009 |
| 05/24/2011 | US7947877 Plants and seeds of spring canola variety SCV328921 |
| 05/24/2011 | US7947876 Plant and plant storage organ having GLP-1 derivative accumulated therein and method of producing the same |
| 05/24/2011 | US7947875 Methods and means for altering fiber characteristics in fiber-producing plants |
| 05/24/2011 | US7947874 Modifying DNA recombination and repair |
| 05/24/2011 | US7947873 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 05/24/2011 | US7947872 Nucleotide sequences involved in plant disease resistance |
| 05/24/2011 | US7947871 Method for producing a transgenic plant with the aid of Agrobacterium thumefaciens |
| 05/24/2011 | US7947870 Generation of plants with altered oil, protein, or fiber content |
| 05/24/2011 | US7947869 Methods for inducing cotton embryogenic callus |
| 05/24/2011 | US7947868 Precise breeding—marker-free transformation |
| 05/24/2011 | US7947867 Ripening inhibition in the tomato Green-ripe mutant results from ectopic expression of a novel protein which disrupts ethylene signal transduction |
| 05/24/2011 | US7947823 siRNA expression system |
| 05/24/2011 | US7947821 Optimized DNA sequences encoding recombinant human bone morphogenetic protein-2 (rhBMP-2), preparation method and the uses thereof |
| 05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
| 05/24/2011 | US7947805 BCMA polypeptides and uses thereof |
| 05/24/2011 | US7947660 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 05/24/2011 | US7947659 iRNA agents targeting VEGF |
| 05/24/2011 | US7947658 RNA interference for the treatment of gain-of-function disorders |
| 05/24/2011 | US7947657 Method for selective inhibition of human N-myc gene in N-myc expressing tumors through antisense and antigen peptido-nucleic acids (PNA) |
| 05/24/2011 | US7947501 Gene recombination exchange system for stable gene modification in human ES cells |
| 05/24/2011 | US7947498 Embryonic stem cells and neural progenitor cells derived therefrom |
| 05/24/2011 | US7947497 Methods for vitrification of human oocytes |
| 05/24/2011 | US7947496 Screening for cytotoxic end-points; cancerous disease modifying antibodies |
| 05/24/2011 | US7947495 Immunoglobulin display vectors |
| 05/24/2011 | US7947494 Fusion protein comprising an E. coli chaperone protein and a human chaperone protein |
| 05/24/2011 | US7947493 Expression vector comprising encephalomyocarditis viral protein for use as tool in designing agents which prevent or treat viral infection; viricides |
| 05/24/2011 | US7947486 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 05/24/2011 | US7947481 Chondroitin synthase, method for producing the same and method for producing saccharide chain-extended chondroitin |
| 05/24/2011 | US7947480 Everninomicin biosynthetic genes |
| 05/24/2011 | US7947479 Bardet-Biedl susceptibility gene and uses thereof |
| 05/24/2011 | US7947476 Analytical method and kit |
| 05/24/2011 | US7947474 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
| 05/24/2011 | US7947473 Methods for expression and purification of pegylated recombinant human growth hormone containing a non-naturally encoded keto amino acid |
| 05/24/2011 | US7947472 An expression vector comprising a sequence of human DNA encoding vascular endothelial growth factor-D (VEGF-D) or a fragment having the biological activity of VEGF-D, inserted into a mammalian expression vector |
| 05/24/2011 | US7947470 Comprises organic cation transporter polypeptide for use in diagnostic, prevention and treatment of metabolic and cell proliferative disorders |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947458 Placental human neurokinin B precursor |
| 05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
| 05/24/2011 | US7947448 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 05/24/2011 | US7947291 Modified surface antigen |
| 05/24/2011 | US7947290 Protease-resistant modified SEB and vaccine containing the same |
| 05/24/2011 | US7947288 Viral particles encoding multifunctional cytokines |
| 05/24/2011 | US7947287 Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors |
| 05/24/2011 | US7947281 Chimeric proteins that induce effects directed against viruses |
| 05/24/2011 | US7947273 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma |
| 05/24/2011 | US7947272 Using mixture comprising inhibitors of CD4, CD25 and interleukin induction as tool in reducing immune response to tissue graft; preventing transplant rejection |
| 05/24/2011 | CA2549985C Formulations and methods for denaturing proteins |
| 05/24/2011 | CA2541651C Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 05/24/2011 | CA2495650C Continuous culture of conifer embryogenic tissue |
| 05/24/2011 | CA2483012C Oligonucleotide compositions and their use for the modulation of immune responses |
| 05/24/2011 | CA2482945C Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 05/24/2011 | CA2459251C Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
| 05/24/2011 | CA2453571C Vascular tissue preferred promoters |
| 05/24/2011 | CA2453001C Method of testing a mammal for its predisposition for fat content of milk and/or its predisposition for meat marbling |
| 05/24/2011 | CA2450467C Methods for modulating bladder function |
| 05/24/2011 | CA2440596C Soluble heterodimeric cytokine receptor |
| 05/24/2011 | CA2434059C Constitutive promoter from arabidopsis |
| 05/24/2011 | CA2402534C Mrna amplification |
| 05/24/2011 | CA2401604C Method of treating cancer with anti-neurotrophin agents |
| 05/24/2011 | CA2394792C Promoter and intron from maize actin depolymerizing factor |
| 05/24/2011 | CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby |
| 05/24/2011 | CA2380616C Process for the biological production of 1,3-propanediol with high titer |
| 05/24/2011 | CA2374215C New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 05/24/2011 | CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 05/24/2011 | CA2338751C Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 05/24/2011 | CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 05/24/2011 | CA2323072C Gfr.alpha.3 and its uses |
| 05/24/2011 | CA2319310C Equine fc epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and uses thereof |
| 05/24/2011 | CA2270913C Human tumor necrosis factor receptor-like 2 |
| 05/24/2011 | CA2247067C Meltrins |
| 05/24/2011 | CA2229631C Gene therapy using ovine adenoviral vectors |
| 05/24/2011 | CA2214116C Novel endoglucanases |
| 05/24/2011 | CA2211687C Vascular endothelial growth factor-b |
| 05/24/2011 | CA1341615C Targeted multifunctional proteins |
| 05/24/2011 | CA1341614C Targeted multifuncional proteins |
| 05/19/2011 | WO2011060320A1 Antisense antiviral compound and method for treating influenza viral infection |
| 05/19/2011 | WO2011060182A1 Monoclonal antibodies against gmf-beta antigens, and uses therefor |
| 05/19/2011 | WO2011060065A2 Instillation of liposomal formulation of sirna and antisense oligonucleotides |
| 05/19/2011 | WO2011059801A1 Solution assay and high through-put screen to probe interaction between human cullin-ring ligase complex and hiv-vif protein |
| 05/19/2011 | WO2011059799A1 Multifunctional alleles |
| 05/19/2011 | WO2011059752A1 Methods and compositions for anti-egfr treatment |
| 05/19/2011 | WO2011059740A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 05/19/2011 | WO2011059538A1 Viral promoter, truncations thereof, and methods of use |
| 05/19/2011 | WO2011059453A1 Methods for producing surface bound oligonucleotide on solid substrate and uses thereof |
| 05/19/2011 | WO2011059332A2 Improved immunomodulation by probiotics |
| 05/19/2011 | WO2011059092A1 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated |
| 05/19/2011 | WO2011059051A1 Flowering inducer |